
The Pharmacy Council of India (PCI) in collaboration with the Quality Council of India (QCI) has launched a revolutionary rating system to assess and rank pharmacy colleges in the country. The initiative is meant to usher in more transparency, accountability, and quality assurance in the pharmacy education system in India.
This new structure will grade institutions based on a broad range of criteria, thus enabling parents and students to make highly informed choices about where they can best take their pharmacy studies. It also establishes a new standard that colleges will strive towards in their quest for academic and operational superiority.
The recently introduced rating system by the PCI and QCI is aimed at establishing uniformity and transparency in assessing pharmacy colleges. By evaluating institutions on various parameters, the system aims to enhance the overall quality of pharmacy education in the country.
Colleges will be ranked on 11 specific parameters, such as:
Infrastructure Quality: Institutions will be graded on the availability, safety, and upgradation of classrooms, laboratories, libraries, and other facilities.
Faculty Credentials: The academic and professional qualifications of the faculty, their experience, and research contributions in the discipline will be evaluated.
Research Output: Institutions will be rated on their research productivity such as publications, funded projects, and innovations in the pharmaceutical sector.
Academic Achievement: Student passing rates, test scores, and curriculum delivery will be essential elements of assessment.
Placement Achievement: Colleges will be required to present measurable information on graduate placements, internship opportunities, and employer partnerships.
Student Services, Governance, and Alumni Engagement will also factor into the final rating.
Pharmacy institutions intending to participate in the 2025-26 academic year must adhere to the following schedule:
May 15-30, 2025: Registration and fee submission period.
June 1 - July 7, 2025: Submission of inspection and assessment applications.
An assessment fee of ₹1 lakh is charged to participating institutions. Colleges also need to undergo orientation programs organized by the QCI and submit requisite information through an online portal according to guidelines.
This program will have a broad set of advantages for the stakeholders and institutions alike:
Improved Transparency: Students and parents will have a credible, objective point of reference when selecting colleges.
Informed Choice: With institutional ratings that are verified, applicants can choose institutions that meet their academic aspirations and expectations.
Quality Enhancement: Colleges will be incentivized to improve their infrastructure, appoint trained teachers, and spend more on research and development to attain improved ratings.
National Benchmarking: This framework will also enable comparisons at the national level among institutions, encouraging good competition and innovation in the educational field.
By implementing this rating system, the PCI and QCI aim to foster a culture of excellence and continuous improvement within the pharmacy education sector.
The PCI’s introduction of a formal rating mechanism in collaboration with QCI marks a watershed moment for pharmacy education in India. By prioritizing transparency and quality, the initiative is not only set to guide students more effectively but also to encourage educational institutions to raise their standards in every aspect—from infrastructure to innovation. As colleges gear up for implementation ahead of the 2025–26 academic cycle, this bold step promises to reshape the future of pharmaceutical education across the country.
(Input from various sources)
(Rehash/Sakshi Thakar/MSM)